Data is not available at this time.
Bastide Le Confort Médical SA operates in the medical equipment and services sector, specializing in the sale and rental of health and comfort products for elderly and disabled individuals. The company’s diversified portfolio includes mobility aids, home support equipment, incontinence products, and wellness solutions, distributed through a network of 130 physical stores and an e-commerce platform. Its integrated approach combines product offerings with home support services, positioning it as a key player in France’s aging population market. The company’s focus on accessibility and convenience aligns with growing demand for home healthcare solutions, driven by demographic trends and increasing preference for non-institutional care. While it faces competition from larger medical suppliers and online retailers, its localized store presence and specialized product range provide a competitive edge in serving regional customer needs.
The company reported revenue of €529.8 million for the fiscal year, reflecting its strong market presence in France. However, net income was negative at €-0.9 million, with diluted EPS of €-0.12, indicating profitability challenges. Operating cash flow stood at €66.0 million, suggesting reasonable operational efficiency, though capital expenditures of €-55.4 million highlight ongoing investments in infrastructure and inventory.
Despite revenue scale, the negative net income points to margin pressures, possibly from competitive pricing or operational costs. The operating cash flow-to-revenue ratio of approximately 12.5% indicates moderate cash generation, but elevated capital expenditures relative to cash reserves (€23.6 million) suggest constrained free cash flow. Debt levels at €408.6 million further weigh on capital efficiency.
The company’s financial health is mixed, with €23.6 million in cash against total debt of €408.6 million, indicating high leverage. The absence of dividends aligns with its focus on debt management and reinvestment. The balance sheet reflects the capital-intensive nature of its business model, with significant liabilities tied to inventory and store operations.
Growth is likely tied to demographic trends favoring home healthcare, though recent profitability challenges may slow expansion. The company has not issued dividends, prioritizing liquidity and debt reduction. Future growth may depend on optimizing store performance and expanding digital sales channels to offset margin pressures.
With a market cap of €215.6 million and a beta of 0.879, the stock exhibits moderate volatility relative to the market. The negative earnings and high debt load suggest cautious investor sentiment, though the company’s niche market position could support long-term valuation if profitability improves.
Bastide Le Confort Médical’s strategic advantage lies in its specialized product range and localized distribution network. However, operational efficiency and debt management remain critical challenges. The outlook hinges on its ability to capitalize on aging demographics while improving margins through cost controls and e-commerce growth.
Company description, financial data from disclosed filings, and market metrics from exchange sources.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |